Zymtronix joins Terra food and agtech accelerator cohort III

Zymtronix has been selected to team up with multinational leader Tate & Lyle to fuel groundbreaking transformation in food and agriculture

Terra, the leading food and agriculture accelerator, has selected Zymtronix into its third cohort kicking off next week in San Francisco — near the headquarters of RocketSpace — one of the programme’s founding partners.

Zymtronix was selected as one of the 17 most innovative startups from across the globe to work alongside industry giants including founding partner Rabobank, as well as AgroFresh, Beta San Miguel, Graincorp, Griffith Foods, Grupo Azucarero Mexico/CULTIBA, Nestlé USA and Tate & Lyle.

Zymtronix will partner with Tate & Lyle, a global provider of ingredients and solutions to food, beverage and industrial markets.

“We are excited to start our pilot with Tate & Lyle, and implement our most recent advances in enzyme immobilisation and stabilisation applied to flow processes for food ingredient production,” said Stéphane Corgié, founder and CEO-CTO, Zymtronix.

Founded in 2016, Terra is a global innovation accelerator fuelling groundbreaking transformation in food and agriculture to advance the well-being of our people and planet.

The programme brings together experts, decision makers and innovators across the entire value chain — fostering connections that catapult major breakthroughs into scalable solutions by pairing emerging growth companies with established multinationals, in a pilot-driven engagement that leads to tangible results.

The Terra team reviewed hundreds of applications from emerging growth companies around the world, shortlisting 160 applicants for only 17 spots.

Startups selected represent eight countries. Unlike other accelerators, Terra does not require equity from selected startups. They must have a product in market/ready to launch and have raised a minimum of seed-funding, better positioning them for productive pilot partnerships with corporate collaborators.

Zymtronix is an emerging biotech company with an in-market platform for discovery and production of small molecules by innovating on materials that mimic cell-like structures for optimal enzyme processes at industrial scale.

Companies